TMCnet News
cliexa's Explainable Clinical AI and Measured Fairness Gains Featured in Mayo Clinic Platform Case StudyPublished evaluation reports a 76% reduction in the racial performance gap for high-risk opioid use disorder detection and documents a reasoning-first architecture's progression toward enterprise deployment. DENVER, Sept. 15, 2026 /PRNewswire/ -- cliexa, the clinical reasoning layer for healthcare, today announced the publication of a Mayo Clinic Platform case study documenting the development, evaluation and commercial preparation of cliexaAI Opioid Use Disorder Solution. The case study details how cliexa combined evidence-grounded clinical rules with predictive AI, measured performance across patient groups, and progressed through clinical validation to Mayo Clinic Platform qualification and a pathway to enterprise deployment. The publication comes as healthcare organizations place greater emphasis on the evidence supporting AI adoption. In its 2026 physician survey findings, the American Medical Association reported that 88% of physicians identified robust safety and efficacy validation as critical to broader AI adoption, with clinical evidence and practical implementation guidance among the most requested resources. "Generating an answer is not the same as making a clinical decision defensible," said Mehmet Kazgan, founder and CEO of cliexa. "Our focus is the reasoning between the record and the decision: the clinical evidence, the patient context and the explanation a clinician can inspect. This case study documents the development and evaluation behind that approach, not just what the technology is intended to do." Measured performance, including results across patient groups The reported bias-mitigation results include:
A clinical reasoning layer, not another system to replace Across cliexa's broader platform, the reasoning approach supports Admissions, Documentation Integrity, Care Coordination and Revenue, connecting patient context with the requirements surrounding entry into care, clinical documentation, transitions and claim submission. Enterprise Intelligence provides a cross-functional interface for questions spanning clinical, operational and financial data. cliexa is designed to work with existing electronic medical records and healthcare applications. Its API-first architecture also allows technology partners to embed capabilities such as documentation scoring, medical-necessity validation, denial-risk assessment and appeals within their own products. The case study describes preparation for enterprise deployment through EMR-agnostic and on-premises-capable implementation patterns. A documented development pathway, with work beyond OUD The publication also describes how the engagement strengthened cliexa's development practices, making fairness analysis, explainability, demographic auditing and pre-registered evaluation criteria standard expectations across model development. The full case study, "From records to reason®: How cliexa advanced explainable clinical AI with Mayo Clinic Platform," is available on Mayo Clinic Platform's website. About cliexa
SOURCE cliexa, Inc.
|
